Current Highlight from May 9, 2014
Progress on FDS Studies Reviewed by TSSRC
The 43rd meeting of the Toxicology Study Selection and Review Committee (TSSRC) was held May 6 at NCTR. The meeting's purpose was to discuss ongoing studies that are part of the Interagency Agreement between FDA/NCTR and the National Institute of Environmental Health Sciences/National Toxicology Program (NIEHS/NTP) that supports toxicology studies providing data for the FDA risk-assessment process.
Ongoing studies at NCTR in the following areas were discussed:
Ongoing studies at NCTR in the following areas were discussed:
- Food contaminants (Bisphenol A, melamine + cyanuric acid, nanosilver)
- Topically applied compounds (retinyl palmitate and oxybenzone)
- Antibacterial chemicals (triclosan)
- Medical device components (nanosilver)
Future studies on aloe vera and melamine + cyanuric acid were also discussed. The NIEHS/NTP presented updates on the NTP and the NIEHS/NTP Toxicology Testing Program.
The TSSRC is comprised of regulatory scientists and subject-matter experts from the FDA Product Centers (CBER, CDER, CDRH, CFSAN, CVM, and CTP), the NIEHS/NTP, and the National Institutes of Health (NIH). The committee meets twice each year and is responsible for scientific oversight of study design and progress of ongoing work under this Interagency Agreement. The next meeting of the TSSRC will be held at the FDA White Oak campus, November 12-13, 2014. For more information, contact Dr. Paul C. Howard (paul.howard@fda.hhs.gov).
-
NCTR Research Highlights Archives
-
.png)
No hay comentarios:
Publicar un comentario